Metropolis Healthcare to acquire 51% stake in Shraddha Diagnostic Centre

16 Jan 2020 Evaluate

Metropolis Healthcare has executed Share Purchase and Shareholders' Agreement for the acquisition of 51% shareholding in Shraddha Diagnostic Centre (I). The purpose of the acquisition is to strengthen the presence of the company in the state of Gujarat, India.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

1859.60 -36.05 (-1.90%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6989.30
Max Healthcare Inst 1041.80
Narayana Hrudayalay 1829.70
Aster DM Healthcare 611.20
Global Health 1153.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×